Detalhe da pesquisa
1.
Functionally distinct promoter classes initiate transcription via different mechanisms reflected in focused versus dispersed initiation patterns.
EMBO J
; 42(10): e113519, 2023 05 15.
Artigo
Inglês
| MEDLINE | ID: mdl-37013908
2.
Management of adult patients with CMML undergoing allo-HCT: recommendations from the EBMT PH&G Committee.
Blood
; 143(22): 2227-2244, 2024 May 30.
Artigo
Inglês
| MEDLINE | ID: mdl-38493484
3.
Oncogenic MTOR signaling axis compensates BTK inhibition in a Chronic Lymphocytic Leukemia patient with Richter Transformation: A Case Report and Review of the Literature.
Acta Haematol
; 2024 Feb 24.
Artigo
Inglês
| MEDLINE | ID: mdl-38402867
4.
Cox proportional hazards deep neural network identifies peripheral blood complete remission to be at least equivalent to morphologic complete remission in predicting outcomes of patients treated with azacitidine-A prospective cohort study by the AGMT.
Am J Hematol
; 98(11): 1685-1698, 2023 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-37548390
5.
The ABNL-MARRO 001 study: a phase 1-2 study of randomly allocated active myeloid target compound combinations in MDS/MPN overlap syndromes.
BMC Cancer
; 22(1): 1013, 2022 Sep 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36153475
6.
CD44 engagement enhances acute myeloid leukemia cell adhesion to the bone marrow microenvironment by increasing VLA-4 avidity.
Haematologica
; 106(8): 2102-2113, 2021 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-32616529
7.
Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions.
Haematologica
; 104(10): 1935-1949, 2019 10.
Artigo
Inglês
| MEDLINE | ID: mdl-31048353
8.
Durable remissions with venetoclax monotherapy in secondary AML refractory to hypomethylating agents and high expression of BCL-2 and/or BIM.
Eur J Haematol
; 102(5): 437-441, 2019 May.
Artigo
Inglês
| MEDLINE | ID: mdl-30725494
9.
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
BMC Cancer
; 18(1): 11, 2018 01 03.
Artigo
Inglês
| MEDLINE | ID: mdl-29298682
10.
Correction to: Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Ann Hematol
; 97(9): 1745, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-29934835
11.
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Ann Hematol
; 97(10): 1825-1839, 2018 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-29862437
12.
Reactivation of dormant anti-tumor immunity - a clinical perspective of therapeutic immune checkpoint modulation.
Cell Commun Signal
; 15(1): 5, 2017 Jan 19.
Artigo
Inglês
| MEDLINE | ID: mdl-28100240
13.
The double-edged sword of (re)expression of genes by hypomethylating agents: from viral mimicry to exploitation as priming agents for targeted immune checkpoint modulation.
Cell Commun Signal
; 15(1): 13, 2017 03 31.
Artigo
Inglês
| MEDLINE | ID: mdl-28359286
14.
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group.
Int J Mol Sci
; 18(2)2017 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28212292
15.
Clinical Outcomes of 217 Patients with Acute Erythroleukemia According to Treatment Type and Line: A Retrospective Multinational Study.
Int J Mol Sci
; 18(4)2017 Apr 14.
Artigo
Inglês
| MEDLINE | ID: mdl-28420120
16.
Mesenchymal Stem and Progenitor Cells in Normal and Dysplastic Hematopoiesis-Masters of Survival and Clonality?
Int J Mol Sci
; 17(7)2016 Jun 27.
Artigo
Inglês
| MEDLINE | ID: mdl-27355944
17.
IDO in MDS/AML disease progression and its role in resistance to azacitidine: a potential new drug target?
Br J Haematol
; 190(3): 314-317, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32419137
18.
Digging deep into "dirty" drugs - modulation of the methylation machinery.
Drug Metab Rev
; 47(2): 252-79, 2015 May.
Artigo
Inglês
| MEDLINE | ID: mdl-25566693
19.
Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group.
Ann Hematol
; 93(11): 1825-38, 2014 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-24951123
20.
Myeloid NGS Analyses of Paired Samples from Bone Marrow and Peripheral Blood Yield Concordant Results: A Prospective Cohort Analysis of the AGMT Study Group.
Cancers (Basel)
; 15(8)2023 Apr 14.
Artigo
Inglês
| MEDLINE | ID: mdl-37190237